KEGG   DISEASE: ヌーナン症候群類縁疾患
エントリ  
H00523                                                             
名称    
ヌーナン症候群類縁疾患
  下位グループ
ヌーナン症候群 (NS) [DS:H01738]
レオパード症候群 (LPRD) [DS:H01984]
CFC 症候群 [DS:H01745]
コステロ症候群 [DS:H01747]
神経線維腫性ヌーナン症候群 (NFNS) [DS:H02189]
成長期脱毛を伴うヌーナン様症候群 (NSLH) [DS:H02191]
CBL 症候群 [DS:H02190]
概要    
Noonan syndrome comprises genetically heterogeneous disorders that usually include postnatally reduced growth, distinctive facial dysmorphic features, and congenital heart defects and related disorders show considerable overlapping phenotypes with Noonan syndrome. These disorders are caused by germline mutations in genes that encode components or regulators of the Ras/MAPK pathway, and are called RASopathies.
カテゴリ  
先天奇形
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 20 発達異常
  多発性の発達異常または症候群
   LD2F  多発性の構造異常を伴う症候群, 主な体系の関与を伴わないもの
    H00523  ヌーナン症候群類縁疾患
パスウェイに基づく疾患分類 [BR:jp08402]
 シグナル伝達
  nt06526  MAPK シグナリング
   H00523  ヌーナン症候群類縁疾患
パスウェイ 
hsa04014  Ras signaling pathway
hsa04010  MAPK signaling pathway
hsa04910  Insulin signaling pathway
hsa01521  EGFR tyrosine kinase inhibitor resistance
hsa04012  ErbB signaling pathway
hsa04650  Natural killer cell mediated cytotoxicity
hsa04810  Regulation of actin cytoskeleton
ネットワーク
nt06526 MAPK signaling
病因遺伝子 
(NS1/LPRD1) PTPN11 [HSA:5781] [KO:K07293]
(NS3/CFC2) KRAS [HSA:3845] [KO:K07827]
(NS4) SOS1 [HSA:6654] [KO:K03099]
(NS5/LPRD2) RAF1 [HSA:5894] [KO:K04366]
(NS6) NRAS [HSA:4893] [KO:K07828]
(NS7/LPRD3/CFC1) BRAF [HSA:673] [KO:K04365]
(NS8) RIT1 [HSA:6016] [KO:K07832]
(NS9) SOS2 [HSA:6655] [KO:K03099]
(NS10) LZTR1 [HSA:8216] [KO:K23330]
(CFC3) MAP2K1 [HSA:5604] [KO:K04368]
(CFC4) MAP2K2 [HSA:5605] [KO:K04369]
(CS) HRAS [HSA:3265] [KO:K02833]
(NFNS) NF1 [HSA:4763] [KO:K08052]
(NSLH1) SHOC2 [HSA:8036] [KO:K19613]
(NSLH2) PPP1CB [HSA:5500] [KO:K06269]
(CBL) CBL [HSA:867] [KO:K04707]
リンク   
ICD-11: LD2F.1Y
ICD-10: Q87.1
MeSH: D009634 D044542 D056685
OMIM: 163950 151100 611553 611554 115150 218040 601321 607721 613563
文献    
  著者
Tartaglia M, Gelb BD, Zenker M
  タイトル
Noonan syndrome and clinically related disorders.
  雑誌
Best Pract Res Clin Endocrinol Metab 25:161-79 (2011)
DOI:10.1016/j.beem.2010.09.002
文献    
PMID:8317503
  著者
Tassabehji M, Strachan T, Sharland M, Colley A, Donnai D, Harris R, Thakker N
  タイトル
Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a family with features of Watson syndrome and Noonan syndrome.
  雑誌
Am J Hum Genet 53:90-5 (1993)
文献    
  著者
Aoki Y, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, Ogata T, Takada F, Yano M, Ando T, Hoshika T, Barnett C, Ohashi H, Kawame H, Hasegawa T, Okutani T, Nagashima T, Hasegawa S, Funayama R, Nagashima T, Nakayama K, Inoue S, Watanabe Y, Ogura T, Matsubara Y
  タイトル
Gain-of-function mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome.
  雑誌
Am J Hum Genet 93:173-80 (2013)
DOI:10.1016/j.ajhg.2013.05.021
文献    
  著者
Rauen KA
  タイトル
The RASopathies.
  雑誌
Annu Rev Genomics Hum Genet 14:355-69 (2013)
DOI:10.1146/annurev-genom-091212-153523
文献    
  著者
Roberts AE, Allanson JE, Tartaglia M, Gelb BD
  タイトル
Noonan syndrome.
  雑誌
Lancet 381:333-42 (2013)
DOI:10.1016/S0140-6736(12)61023-X
LinkDB    

» English version

DBGET integrated database retrieval system